Prognostic Stratification and Importance of Follow-Up
- PMID: 32091722
- Bookshelf ID: NBK553849
- DOI: 10.1007/978-3-030-13864-6_12
Prognostic Stratification and Importance of Follow-Up
Excerpt
In the last decades, long-term survival of patients affected by dilated cardiomyopathy (DCM) has been markedly improved. The main milestones, such as the early diagnosis and the systematic follow-up, the proper etiological characterization at the onset of the disease, and a multidisciplinary approach to the patients together with the optimal medical and device treatment and the rigorous tailored follow-up, accompanied these prognostic improvements. However, DCM still remains the most common cause of heart transplantation and one of the leading causes of cardiac death in the western world. Therefore, proper prognostic stratification and systematic follow-up are the cornerstones to optimize medical management and improve outcomes of patients with DCM.
Copyright 2019, The Author(s).
Sections
- 12.1. Prognosis of DCM: The Milestones of the Management
- 12.2. Etiological Characterization as an Important Prognostic Factor
- 12.3. DCM as a Dynamic Disease: The Importance of Follow-Up
- 12.4. Left Ventricular Reverse Remodeling Beyond the Left Ventricle
- 12.5. Prognostic Role of Cardiopulmonary Exercise Testing
- 12.6. Arrhythmic Risk Stratification
- 12.7. The “Apparent Healing” Phenomenon
- 12.8. Uninterrupted Follow-Up and Continuous Reclassification of the Disease
- References
References
-
- Hershberger RE, Hedges DJ, Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10(9):531–47. https://doi.org/10.1038/nrcardio.2013.105. - DOI - PubMed
-
- Merlo M, Cannata A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228–39. https://doi.org/10.1002/ejhf.1103. - DOI - PubMed
-
- Merlo M, Cannata A, Vitagliano A, Zambon E, Lardieri G, Sinagra G. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev Cardiovasc Ther. 2016;14(2):137–40. https://doi.org/10.1586/14779072.2016.1125292. - DOI - PubMed
-
- Merlo M, Gentile P, Naso P, Sinagra G. The natural history of dilated cardiomyopathy: how has it changed? J Cardiovasc Med (Hagerstown). 2017;18(Suppl 1):e161–e5. https://doi.org/10.2459/JCM.0000000000000459. - DOI - PubMed
-
- Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014;16(3):317–24. https://doi.org/10.1002/ejhf.16. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources